Add Seer Company with airSlate SignNow

Add seer company

[Music] hello welcome to up your mind watch my name is mike i want to thank you very much for taking the time to watch this video i want to make one uh wanna talk something that's besides uh has nothing to do with this video it's about yesterday's video with airbnb i want to first apologize because i put a picture that wasn't mine okay so that's my mistake is that i used the picture um not that there was a infringement or anything like that but that i got that picture from google images and it had some kind of writing on it the airbnb picture it had in small white uh writing that sort of faded with the picture and i didn't notice what was on there um until after in the morning here um when i woke up and i got emails and i looked at it and i noticed that what it was saying was just disgusting horrible and you can't even describe it in words how horrible that message was i have nothing to do with it i didn't create that picture i didn't put those words on that picture so i took down the video and that's it um had none do with that um so i'm sorry about that uh um my mistake is that i i did not see what was written on that picture okay so anyways uh in this video we're going to talk about seer it's a pharmaceutical company and it is going public tomorrow december 4th 2020 ticker symbol s e e r s e e r and uh so let's look into this syria they develop innovative solutions that act as a gateway to the proteome proteome our goal is to empower the scientific community with tools to achieve exceptional outcomes we do this by removing the technological barriers that stand between breakthrough ideas and the information that can make them a reality over the last 15 years the fields of g genomics and trans crypto transcriptomics have undergone an explosion in content and discovery fueled by massively parallel technologies that made large-scale studies possible and tractable advancement in those fields have deepened our understanding of biology etc from their website um so syria has filed to raise 150 million dollars in an initial public offering of its class a common stock the firm is preparing to commercialize its protein analysis system so it has a protein analysis system that they are ready to commercialize they intend to raise 150 million dollars from the cell the company is developing an integrated system to assist biopharmaceutical and academic researchers in analyzing proteins it has additional investment interest by its existing investors in the firm uh imminent launch into the market in 2021's positives so it's yeah 2021 when i don't know probably the second half uh the redwood city california based company plans to raise uh like we said 150 million dollars by offering 8.8 million shares so 8.8 million shares at a price range of 16 to 18 i think it's expensive already i'm gonna tell you guys that that for me that's expensive i'll explain why in a little bit for the fidelity softbank t-world price and a moon fund have agreed to invest an additional 135 million dollars in concurrent private placement [Music] yeah even though it is expensive to me i see the fidelity i like when fidelity or goldman sachs are investing not not when goldman sachs i mean it's good when goldman sachs is the lead underwriter but if goldman sachs or fidelity are investing in company it's always positive news to me but i still can't i don't like that 18 [Music] price tag for a company that hasn't done anything so far other than say that we have something that we want to commercialize in 2021 i don't have a i don't have a pass to try to grasp and understand and get something out of them um the company aims to commercialize their proteom research products starting with its initial product the proteograph product suit shear will leverage its proprietary engineering nanoparticle and p technology to provide rapid large scale axis across its the proteome so the proteograph product suit is an integrated solution that is comprised of consumables and automation instrument and software and will be sold and marketed for research use only its first proteogra its first protograph was delivered to one of its first collaborators in october 2020 and the company expects to place another protograph with a second collaborator before the end of 2020 pending any coveted 19 related delays siri is seeking a large ipo amount for a product company that doesn't have significant product revenue that they don't just now in 2020 they did one collaboration for their product and hoping for a second one and then i don't know what um the first the firm's system is planned for initial limited release among small number of marquee clients in 2021 management expects to begin product commercialization in 2022 so i don't know why yeah so i i don't understand why they have to wait till 2022 to begin broader commercialization so right off the bat you can tell that in 2021 they're not going to be uh beating earnings expectations or anything um so what do i think i wouldn't i i'm not going to invest personally i'm not because it's 18 and it might be higher by the time it goes public but even if that at 18 18 a share i can find already existing stocks on the market that would give me better value uh for now and so i'm not going to put my money on that um but because fidelity is involved in it and because they have some sort of product that they're ready to start selling i would definitely add them on my watch list just to keep myself updated with the newest and you never know maybe later on i would be ready to invest that's just my personal opinion that's that's doesn't mean that you should do the same so don't forget december 4th 2020 they're going public take your symbol s e e r um if you if you have any questions please let me know in the comment section below and uh thank you very much for watching this video